Publication | Closed Access

Enhancement of Metabolic Coronary Dilatation by Aspirin-like Substances by Suppression of Prostaglandin Feedback Control?

Cardiovascular DiseaseProstaglandin Feedback ControlMedicinePhysiologyCardiologyVascular BiologyPharmacotherapyEndocrinologyPharmacologyPlatelet AntagonistAtherosclerosisAspirin-like SubstancesCoronary Artery DiseaseMetabolic Coronary Dilatation